Onward Medical N.V.
ONWRF
$5.70
-$0.42-6.86%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.95M | 2.39M | 1.88M | 853.20K | -203.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.95M | 2.39M | 1.88M | 853.20K | -203.90K |
| Cost of Revenue | 14.42M | 14.59M | 15.04M | 14.83M | 14.54M |
| Gross Profit | -11.46M | -12.20M | -13.16M | -13.98M | -14.75M |
| SG&A Expenses | 22.23M | 20.54M | 19.39M | 18.60M | 17.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 42.22M | 40.42M | 39.57M | 38.95M | 38.12M |
| Operating Income | -39.27M | -38.02M | -37.69M | -38.09M | -38.33M |
| Income Before Tax | -41.58M | -39.66M | -38.69M | -38.59M | -38.30M |
| Income Tax Expenses | 497.80K | 224.60K | -42.70K | -157.50K | -276.60K |
| Earnings from Continuing Operations | -42.08 | -39.88 | -38.65 | -38.43 | -38.02 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -42.08M | -39.88M | -38.65M | -38.43M | -38.02M |
| EBIT | -39.27M | -38.02M | -37.69M | -38.09M | -38.33M |
| EBITDA | -38.53M | -37.31M | -36.99M | -37.42M | -37.69M |
| EPS Basic | -0.87 | -0.88 | -0.92 | -1.05 | -1.17 |
| Normalized Basic EPS | -0.53 | -0.55 | -0.58 | -0.66 | -0.74 |
| EPS Diluted | -0.87 | -0.88 | -0.92 | -1.05 | -1.18 |
| Normalized Diluted EPS | -0.53 | -0.55 | -0.58 | -0.66 | -0.74 |
| Average Basic Shares Outstanding | 198.54M | 188.53M | 178.52M | 154.12M | 129.73M |
| Average Diluted Shares Outstanding | 198.54M | 188.53M | 178.52M | 154.12M | 129.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |